Effect of topical Simvastatin in treatment of Bedsore
Phase 2
Recruiting
- Conditions
- Bed sore.
- Registration Number
- IRCT20200602047634N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Patients who sign informed consent
Patients with Diabetes
Patients with grade 2 or 3 Bedsores
Exclusion Criteria
Patients with a history of allergy to Statins
Patients who are pregnant or lactating
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 30% reduction in wound size. Timepoint: Measure the size of the wound at the beginning of the study and 7, 14 and 21 days after starting topical Simvastatin. Method of measurement: Ruler of wound.
- Secondary Outcome Measures
Name Time Method